Rapidly Growing Nanotechnology Firm Launches New Identity as MIP DiscoveryGemma Cann2022-06-30T12:07:41+01:00May 24th, 2022|Colworth Park, News|
Upperton Pharma Solutions Announces £15m Investment in New FacilitiesGemma Cann2022-06-30T11:25:49+01:00May 23rd, 2022|BioCity Nottingham, News|
Reach Separations Marks 10th Birthday Milestone with Further Expansion into EuropeGemma Cann2022-07-28T15:48:05+01:00May 17th, 2022|BioCity Nottingham, News|
Absolute Antibody to be Featured on “World’s Greatest!…” Television SeriesGemma Cann2022-06-30T11:27:06+01:00May 17th, 2022|News, Wilton Centre|
Amphista Therapeutics Enters Strategic Collaboration with Bristol Myers SquibbGemma Cann2022-06-30T11:27:54+01:00May 4th, 2022|BioCity Glasgow, Investment, News|
Sygnature Discovery Acquires Peak ProteinsGemma Cann2022-06-30T11:28:07+01:00April 28th, 2022|BioCity Nottingham, News|
OMass Therapeutics Raises $100 million to Progress Drug Pipeline in Immunology and Rare DiseasesGemma Cann2022-06-30T11:29:35+01:00April 28th, 2022|BioCity Nottingham, News|
Milestone Anniversary ‘A Proud Landmark’ for V Formation’s DirectorsGemma Cann2022-06-30T12:08:27+01:00April 26th, 2022|BioCity Nottingham, News|
Invizius Awarded Second Biomedical Catalyst GrantGemma Cann2022-06-30T11:30:18+01:00April 26th, 2022|BioCity Glasgow, News|
Wilton Centre Attracts Companies for Green Industrial RevolutionGemma Cann2022-07-04T16:05:08+01:00April 25th, 2022|News, Wilton Centre|
